1. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU,
Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T,
Acikel C, Vural A, Covic A: Relationship between serum magnesium
levels and cardiovascular events in chronic kidney disease patients.
Am J Nephrology 2012; 36: 228-237
2. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH,
Altura BM: Intracellular and extracellular magnesium depletion in
type 2 (non-insulindependent) diabetes mellitus. Diabetologia 1993;
36: 767-770
3. Romani AM: Cellular magnesium homeostasis. Arch Biochem
Biophys 2011; 512: 1-23
4. Schlingmann KP, Waldegger S, Konrad M, Chubanov V, Gudermann
T: TRPM6 and TRPM7: Gatekeepers of human magnesium
metabolism. Biochim Biophys Acta 2007; 1772: 813-821
5. Inoue K, Xiong ZG: Silencing TRPM7 promotes growth/
proliferation and nitric oxide production of vascular endothelial
cells via the ERK pathway. Cardiovasc Res 2009; 83: 547-557
6. Hansson GK: Inflammation, atherosclerosis, and coronary artery
disease. N Engl J Med 2005; 352: 1685-1695
7. Libby P, Okamoto Y, Rocha VZ, Folco E: Inflammation in
atherosclerosis: Transition from theory to practice. Circ J 2010; 74:
213-220
8. Wiles ME, Wagner TL, Weglicki WB: Effect of acute magnesium
deficiency (MgD) on aortic endothelial cell (EC) oxidant production.
Life Sci 1997; 60: 221-236
9. Dickens BF, Weglicki WB, Li YS, Mak IT: Magnesium deficiency
in vitro enhances free radical-induced intracellular oxidation and
cytotoxicity in endothelial cells. FEBS Lett 1992; 311: 187-191
10. Zhou Q, Olinescu RM, Kummerow FA: Influence of low magnesium
concentrations in the medium on the antioxidant system in cultured
human arterial endothelial cells. Magnes Res 1999; 12: 19-29
11. Ferr`e S, Baldoli E, Leidi M, Maier JA: Magnesium deficiency
promotes a pro-atherogenic phenotype in cultured human endothelial
cells via activation of NF-κB. Biochim Biophys Acta 2010; 1802:
952-958
12. Maier JA, Voulalas P, Roeder D, Maciag T: Extension of the lifespan
of human endothelial cells by an IL-1α antisense oligomer.
Science 1990; 249: 1570-1574
13. Ferr`e S, Mazur A, Maier JA : Low Mg induces senescent features
in cultured human endothelial cells. Magnes Res 2007; 20: 66-71
14. Killilea DW, Maier JA: A connection between magnesium deficiency
and aging: New insights from cellular studies. Magnes Res 2008;
21: 77-8215. Killilea DW, Ames BN: Magnesium deficiency accelerates cellular
senescence in cultured human fibroblasts. Proc Natl Acad Sci USA
2008;105: 5768-5773
16. Ford ES: Serum magnesium and ischaemic heart disease: Findings
from a national sample of US adults. Int J Epidemiol 1999; 28: 645-
651
17. Khan AM, Sullivan L, McCabe E, Levy D, Vasan RS, Wang TJ:
Lack of association between serum magnesium and the risks of
hypertension and cardiovascular disease. Am Heart J 2010; 160:
715-720
18. Touyz RM, Yao G: Modulation of vascular smooth muscle cell
growth by magnesium: Role of mitogen-activated protein kinases. J
Cell Physiol 2003; 197: 326-335
19. Shechter M: Magnesium and cardiovascular system. Magnes Res
2010; 23: 60-72
20. Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey
Merz CN: Oral magnesium therapy improves endothelial function
in patients with coronary artery disease. Circulation 2000; 102:
2353-2358
21. Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M:
Oral magnesium supplementation improves vascular function in
elderly diabetic patients. Magnes Res 2010; 23: 131-137
22. Maier JA: Endothelial cells and magnesium: Implications in
atherosclerosis. Clinical Science 2012; 122: 397-407
23. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH,
Altura BM: Intracellular and extracellular magnesium depletion
in type 2 (non-insulindependent) diabetes mellitus. Diabetologia
1993; 36: 767-770
24. Fletcher GF, Sweeney ME, Fletcher BJ: Blood magnesium and
potassium alterations with maximal treadmill exercise testing:
Effects of β-adrenergic blockade. Am Heart J 1991; 121: 105-110
25. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi
AA, Hutchinson RG, Metcalf PA: Associations of serum and dietary
magnesium with cardiovascular disease, hypertension, diabetes,
insulin, and carotid arterial wall thickness: The ARIC study. J Clin
Epidemiol 1995; 48: 927-940
26. Leone N, Courbon D, Ducimetiere P, Zureik M: Zinc, copper and
magnesium and risk for all-causes, cancer and cardiovascular
mortality. Epidemiology 2006; 17: 308-314
27. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A:
Magnesium supplementation helps to improve carotid intima media
thickness in patients on hemodialysis. Int Urol Nephrol 2008; 40:
1075-1082
28. Van Laecke S, Mar´echal C, Verbeke F, Peeters P, Van Biesen
W, Devuyst O, Jadoul M, Vanholder R: The relation between
hypomagnesaemia and vascular stiffness in renal transplant
recipients. Nephrol Dial Transplant 2011; 26: 2362-2369
29. Al-Delaimy WK, Rimm EB, Willettm WC, Stampfer MJ, Hu FB:
Magnesium intake and risk of coronary heart disease among men. J
Am Coll Nutr 2004; 23: 63-70Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL,
Petrovitch H, Yano K, Curb JD: Dietary magnesium intake and the
future risk of coronary heart disease (the Honolulu Heart Program).
Am J Cardiol 2003; 92: 665-669
31. Barbagallo M and Dominguez LJ: Magnesium metabolism in type
2 diabetes mellitus, metabolic syndrome and insulin resistance.
Arch Biochem Biophys 2007; 458: 40-47
32. Guerrero-Romero F, Rodríguez-Morán M: Hypomagnesemia,
oxidative stress, inflammation, and metabolic syndrome. Diabetes
Metab Res Rev 2006; 22: 471-476
33. Song Y, Li TY, van Dam RM, Manson JE, Hu FB: Magnesium intake
and plasma concentrations of markers of systemic inflammation and
endothelial dysfunction in women. Am J Clin Nutr 2007; 85: 1068-
1074
34. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs Jr DR, He K:
Magnesium intake in relation to systemic inflammation, insulin
resistance, and the incidence of diabetes. Diabetes Care 2010; 33:
2604-2610
35. Foley RN, Parfrey PS: Cardiovascular disease and mortality in
ESRD. J Nephrol 1998; 11: 239-245
36. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC:
Electron beam computed tomography in the evaluation of cardiac
calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27:
394-401
37. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London G:
Influence of biochemical alterations on arterial stiffness in patients
with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998;
18: 535-541
38. Speer MY, Giachelli CM: Regulation of cardiovascular calcification.
Cardiovasc Pathol 2004; 13: 63-70
39. Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T,
Kawano Y: Coronary calcification in patients with chronic kidney
disease and coronary artery disease. Clin J Am Soc Nephrol 2009;
4: 1892-1900
40. London GM, Guerin AP, Marchais SJ, Métivier F, Pannier B, Adda
H: Arterial media calcification in end-stage renal disease: Impact
on all-cause and cardiovascular mortality. Nephrol Dial Transplant
2003; 18: 1731-1740
41. Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM,
Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker
FW, Ketteler M, Schurgers LJ, Krediet RT, Korevaar JC; NECOSAD
Study Group: Progression of aortic calcification is associated with
disorders of mineral metabolism and mortality in chronic dialysis
patients. Nephrol Dial Transplant 2011; 26: 1662-1669
42. Moe SM, Chen NX: Pathophysiology of vascular calcification in
chronic kidney disease. Circ Res 2004; 95: 560-567
43. Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard
K, Ott S, Sprague S, Lameire N, Eknoyan G; Kidney Disease,
Improving Global Outcomes (KDIGO): Definition, evaluation, and
classification of renal osteodystrophy: A position statement from
Kidney Disease Kidney Int 2006; 69: 1945-1953Temmar M, Liabeuf S, Renard C, Czernichow S, Esper
NE, Shahapuni I, Presne C, Makdassi R, Andrejak M, Tribouilloy
C, Galan P,Safar ME, Choukroun G, Massy Z: Pulse wave velocity
and vascular calcification at different stages of chronic kidney
disease. J Hypertens 2010; 28: 163-169
45. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM: Exploring
the biology of vascular calcification in chronic kidney disease:
What’s circulating? Kidney Int 2008; 73: 384-390
46. Sage AP, Lu J, Tintut Y, Demer LL: Hyperphosphatemia-induced
nanocrystals upregulate the expression of bone morphogenetic
protein-2 and osteopontin genes in mouse smooth muscle cells in
vitro. Kidney Int 2011; 79: 414-422
47. Villa-Bellosta R, Millan A, Sorribas V: Role of calcium-phosphate
deposition in vascular smooth muscle cell calcification. Am J
Physiol Cell Physiol 2011; 300: C210-C220
48. Giachelli CM: Vascular calcification mechanisms. J Am Soc
Nephrol 2004; 15: 2959-2964
49. Sun Y, Zeng XR, Wenger L, Cheung HS: Basic calcium phosphate
crystals stimulate the endocytotic activity of cells—inhibition by
anti-calcification agents. Biochem Biophys Res Commun 2003;
312: 1053-1059
50. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K,
Morii H, Giachelli CM: Phosphate regulation of vascular smooth
muscle cell calcification. Circ Res 2000; 87: E10-E17
51. Li X, Yang HY, Giachelli CM: Role of the sodium-dependent
phosphate cotransporter, Pit-1, in vascular smooth muscle cell
calcification. Circ Res 2006; 98: 905-912
52. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ,
Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM:
Human vascular smooth muscle cells undergo vesicle-mediated
calcification in response to changes in extracellular calcium and
phosphate concentrations: A potential mechanism for accelerated
vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-
2867
53. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM,
Weissberg PL: Apoptosis regulates human vascular calcification in
vitro: Evidence for initiation of vascular calcification by apoptotic
bodies. Circ Res 2000; 87: 1055-1062
54. LeGeros RZ: Formation and transformation of calcium phosphates:
Relevance to vascular calcification. Z Kardiol 2001; 90 Suppl 3:
116-124
55. Cheng PT, Grabher JJ, LeGeros RZ: Effects of magnesium on
calcium phosphate formation. Magnesium 1988; 7: 123-132
56. Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T,
Nishio A: Mg21-Ca21 interaction in contractility of vascular
smooth muscle: Mg21 versus organic calcium channel blockers on
myogenic tone and agonistinduced responsiveness of blood vessels.
Can J Physiol Pharmacol 1987; 65: 729-74557. Kircelli F, Peter ME, Sevinc OE, Celenk FG, Yilmaz M, Steppan S,
Asci G, Ok E, Passlick-Deetjen J: Magnesium reduces calcification
in bovine vascular smooth muscle cells in a dosedependent manner.
Nephrol Dial Transplant 2012; 27(2): 514-521
58. Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri
R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, Kamel S,
Lacour B, Drüeke TB, Massy ZA: The calcimimetic R-568 retards
uremia-enhanced vascular calcification and atherosclerosis in
apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis 2009;
205: 55-62
59. Contiguglia SR, Alfrey AC, Miller NL, Runnells DE, Le Geros RZ:
Nature of soft tissue calcification in uremia. Kidney Int 1973; 4:
229-23560. Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V,
Mayopoulou-Symvoulidou D, Kallivretakis N: Mitral annular
calcifications in haemodialysis patients: A possible protective role
of magnesium. Nephrol Dial Transplant 1997; 12: 2036-2037
61. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y: Serum
magnesium concentration is a significant predictor of mortality in
maintenance hemodialysis patients. Magnes Res 2007; 20: 237-244
Thank you for copying data from http://www.arastirmax.com
